The Court of Justice of the European Union has annulled the judgment of the General Court of the European Union of July 2022 dismissing the action brought by Illumina, a US company specialising in genomic sequencing, against the decisions of the European Commission to declare itself competent to analyse its merger with the US company GRAIL, which develops cancer screening tests (case T-123/22 -see EUROPE B12992A27).
Also annulled are several decisions of the European Commission which, in...